Contribution: Industrial Research Assistance Program – Contributions to Firms
Zurich Pharma Inc
$149,764.00
Formulation Development Research Project
FY 2021-22 · 2022-03-01
Summary
Formulation development and in-vitro evaluation of herbal formulation in a capsule dosage form with combination of stomach-specific mucoadhesive microspheres and colon targeted polymeric microspheres for effectively easing the gastric condition symptoms like bloating, indigestion, heartburns, nausea and constipation.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Windsor|Windsor, Ontario, Canada
Recipient Type
For-profit organization
Business Number
807611140
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2023-01-31
Agreement Number
987501
Agreement Start Date
2022-03-01
Agreement Title
Formulation Development Research Project
Agreement Title (French)
Projet de recherche sur la mise au point d'une formulation
Agreement Type
Contribution
Agreement Value
$149,764.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Formulation development and in-vitro evaluation of herbal formulation in a capsule dosage form with combination of stomach-specific mucoadhesive microspheres and colon targeted polymeric microspheres for effectively easing the gastric condition symptoms like bloating, indigestion, heartburns, nausea and constipation.
Description (French)
Mise au point et évaluation in vitro d'une formulation à base de plantes sous forme de gélules avec une combinaison de microsphères mucoadhésives ciblant l'estomac et de microsphères polymères ciblant le côlon pour soulager efficacement les symptômes des troubles gastriques comme les ballonnements, l'indigestion, les brûlures d'estomac, les nausées et la constipation.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Windsor West
Federal Riding (French)
Windsor-Ouest
Federal Riding Number
35117
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
807611140
Recipient City
Windsor|Windsor
Recipient Country
CA
Recipient Legal Name
Zurich Pharma Inc
Recipient Operating Name
Medicap Laboratories
Recipient Postal Code
N8X 4L2
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q4-987501
